Skip to main content
HighlightsHighlights Archive

Final NICE guidance on Prostate Cancer published

NICE has published its final guideline on Prostate Cancer on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments that NICE received during consultation and the responses to these comments. This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way…
Ben Kemp
December 17, 2021
Membership NewsMembership News Archive

Member company offers regulatory partnership to other BIVDA members

Transition into compliance with IVDR necessitates a considerable investment by manufacturers in their Quality Management Systems (QMS) and subsequent certification by Notified Bodies. We are aware that for SMEs in particular this can represent a considerable, sometimes disproportionate, burden. However, one of our SME members has recently successfully completed its Notified Body audit in line with IVDR requirements and has…
Ben Kemp
December 17, 2021
Membership NewsMembership News Archive

Cabinet Office plans changes to UK procurement rules on supplier exclusion

The Cabinet Office has set out new Government measures which will see the exclusion of poor performing suppliers, as the UK departs from EU procurement laws. The plans would see exclusion criteria being changed to better suit the UK’s legal landscape. As a result, suppliers may be excluded from a contract based on their past performance, only where that performance…
Ben Kemp
December 17, 2021
Membership NewsMembership News Archive

UK Health Security Agency (UKHSA): COVID Biobank

As the UK’s first laboratory responder to the COVID-19 pandemic, UKHSA has a unique collection of COVID samples from the onset and throughout the ongoing pandemic. A biobank of UKHSA’s residual samples has been established to provide a vital resource for the curation and distribution of samples to strengthen research, evaluations and diagnostic development in the field. Please contact the…
Ben Kemp
December 17, 2021
Membership NewsMembership News Archive

Diagnostics Growth Hub

The Diagnostics Growth Hub connects innovative companies with expertise from the London health and life sciences ecosystem. The Hub supports diagnostic development, evaluation, validation and implementation to place London and the UK as leaders in diagnostic development and scale. BIVDA have recently taken part in an expert scoring group for a funding exercise for Medcity, Collaborate to Innovate. They are…
Ben Kemp
December 17, 2021
HighlightsHighlights Archive

Media Monitoring: 11/12 – 17/12

UKHSA ramps up testing availability following record week for distribution The UK’s testing programme is the biggest in Europe with nearly 400 million tests carried out to date, twice the number in France and more than four times the number in Germany So far this week around 400,000 test kits have been delivered to people’s homes each day to help…
Ben Kemp
December 17, 2021
HighlightsHighlights Archive

UK-Australia Free Trade Agreement chapter on antimicrobial resistance

The FTA between the UK and Australia – which was covered in the “International Trade Updates” article in Membership News – includes a chapter explicitly referencing antimicrobial resistance. It states both the UK and Australia’s acknowledgement that AMR poses a serious risk to human and animal health and includes measures which aim to combat the threat. The chapter can be…
Ben Kemp
December 17, 2021
Membership NewsMembership News Archive

International Trade Updates

As a member of the Life Science Trade Advisory Group, or TAG, Doris-Ann goes to briefings on progress of Free Trade Agreements (FTAs) from the Dept. of International Trade and diplomats around the world. Some of these are Life Science specific but some are more general. In most cases the information covered is subject to the NDA but if member…
Ben Kemp
December 17, 2021